Meaghan M. Phipps, MD

Andrew J. Einstein is a cardiologist, cardiac imager, and researcher at Columbia University Irving Medical Center and NewYork-Presbyterian Hospital. He serves as Director of Nuclear Cardiology, Cardiac CT, and Cardiac MRI, Director of the Advanced Cardiac Imaging Fellowship, and a tenured Professor of Medicine, with primary appointment in the Department of Medicine and secondary appointment in the Department of Radiology. Born and raised in New Jersey, Dr. Einstein received an A.B. from Princeton University and attended Mount Sinai School of Medicine, where he received an M.D. as well as a Ph.D. in the Department of Biomathematical Sciences. His graduate research focused on developing image analysis methodology in microscopy. He also received an M.S. in patient-oriented research/biostatistics from Columbia's Mailman School of Public Health. After internship and residency in internal medicine at Rutgers Robert Wood Johnson Medical School, he completed fellowship training at Mount Sinai.Dr. Einstein’s clinical activities are centered on cardiovascular PET, SPECT, CT, and MRI, and he serves on the attending physician staff in the Heart Institute. His research, which uses each of these modalities, focuses on improving the use of imaging in cardiovascular medicine, with particular interests and current funded projects in quality of healthcare, radiation safety, global health, amyloidosis, artificial intelligence, and device development. It is funded by multiple NIH grants, the International Atomic Energy Agency, and industry.Dr. Einstein is the author or coauthor of over 300 papers and abstracts, in leading journals including the New England Journal of Medicine, JAMA, Lancet, BMJ, Circulation, and the Journal of the American College of Cardiology. This work has been influential in affecting clinical practice, and has been widely reported in the popular media and cited over 16,000 times in the scientific literature. For it, Dr. Einstein has received the American College of Cardiology's Douglas P. Zipes Distinguished Young Scientist Award, the Society of Nuclear Medicine and Molecular Imaging’s Hermann Blumgart Award, the American Federation for Medical Research's Junior Physician Investigator Award, and the Lewis Katz Cardiovascular Research Prize for a Young Investigator.He is a member of the editorial boards of JACC: Cardiovascular Imaging and the Journal of Nuclear Cardiology, and served as an Associate Editor of the Journal of Cardiovascular Computed Tomography. He is frequently invited to lecture on subjects related to cardiovascular imaging, and has addressed organizations such as the American Heart Association, American College of Cardiology, European Society of Cardiology, International Atomic Energy Agency, U.S. Food and Drug Administration, and the U.S. Senate in an AAAS Center for Science, Technology and Security Policy briefing. He has served as a member of study sections of the Center for Scientific Review, National Heart, Lung, and Blood Institute, and National Cancer Institute. He is Chair of the Academic Cardiology Section of the American College of Cardiology, and a member of the boards of directors of the American Society of Nuclear Cardiology and the Cardiovascular Council of the Society of Nuclear Medicine and Molecular Imaging. He serves as a member of the Congressionally-chartered National Council on Radiation Protection and Measurements and of the U.S. Nuclear Regulatory Commission’s Advisory Committee on the Medical Uses of Isotopes, and previously served as a voting member of the Food and Drug Administration’s Medical Imaging Drugs Advisory Committee. Dr. Einstein has served as a mentor to over fifty trainees at various stages ranging from high school to junior faculty.

Scott E. Brodie, MD, Ph.D., is a Professor of Clinical Ophthalmology and Attending Ophthalmologist in the Department of Ophthalmology. He is an internationally known clinician-scientist, and a leader in the use of electrophysiologic techniques for diagnosing of visual impairments in children and adults.Dr. Brodie is a graduate of the combined MD-PhD program at Weill-Cornell Medical College and The Rockefeller University in New York. He completed his PhD in retinal physiology in the laboratory of Nobel Laureate H. K. Hartline, under the supervision of Dr. Floyd Ratliff and Prof. Bruce Knight. He completed a medical internship and residency training in ophthalmology at The New York Hospital, and subsequently received fellowship training in medical retinal disorders and clinical electrophysiology of vision at New York University and Bellevue Hospital under the supervision of Dr. Ronald Carr, with support as a John Kluge Fellow of the Retinitis Pigmentosa Foundation.He is a fellow of the American Academy of Ophthalmology, and a fellow of the Association for Research in Vision and Ophthalmology. He is a member of the International Society for Clinical Electrophysiology of Vision, the International Society for Genetic Eye Disease, and the Ophthalmic Genetics Study Club. Dr. Brodie has been honored with the Senior Achievement Award of the American Academy of Ophthalmology, as well as the Academy's Secretariat Award for Education.Dr. Brodie’s research centers on improving methodologies for electrophysiologic testing, and descriptions of novel findings in patients with inherited and metabolic retinal disorders. He has been a key member of the teams which have introduced important new therapies, including enzyme-replacement therapy for Fabry disease, and intra-arterial chemotherapy for retinoblastoma, which has increased the rate of salvage of diseased eyes in the most severely affected patients from 20% to over 90%.Dr. Brodie has published extensively on electrophysiology and retinal disorders. He has a particular interest in clinical optics, and has served as Chair of the Editorial committee for the American Academy of Ophthalmology’s Basic and Clinical Science Course on Clinical Optics for the past ten years. In his spare time, he enjoys reading mathematics, and playing the oboe in local orchestras and chamber groups.

Monica Lypson MD MHPE is the Rolf H. Scholdager Professor of Medicine at Columbia University Irving Medical Center and the Vice Dean for Medical Education. She previously served as a professor, Vice-Chair of Medicine and Division Director of General Internal Medicine at The George Washington University School of Medical and Health Sciences and was President of the Society of General Internal Medicine from 2021-22. Her work focuses on innovations and improvements in health professions education and assessment, health equity, workforce diversity, faculty development, medical care delivery, and provider communication skills. Dr. Lypson's prior role in government included a position as the Director for Medical and Dental Education for the Veterans Health Administration, where she oversaw undergraduate and graduate medical education across the nation within the Department of Veteran Affairs. Dr. Lypson has held many national roles focused on health professions education, including with the Accreditation Council of Graduate Medical Education, the Association of American Medical Colleges, and the National Board of Medical Examiners. She is a board-certified general internist with significant leadership experience in clinical, educational, and administrative arenas. She is a clinician educator and has published over 100 peer-reviewed publications in top-tier medical education journals in the areas of resident assessment, communication skills, cultural competency education, workforce diversity and faculty development. Dr. Lypson graduated from Brown University and received her medical degree from Case Western Reserve University School of Medicine. She completed her graduate medical training at the Brigham and Women's Hospital in Internal Medicine - Primary Care, an affiliate of Harvard Medical School. Subsequently, she went on to complete a Robert Wood Johnson Clinical Scholars program at the University of Chicago and a master’s in Health Professions Education at the University of Illinois at Chicago. She is also a former Aspen Institute Health Innovators Fellow.